drugset / Trial / NCT02266550
Metabolism and Pharmacokinetics of [14C]-BIIL 284 BS in Healthy Volunteers
NaSingle-groupOpen-labelTreatment
Summary
The aims of this phase I study are to define the metabolism, excretion and pharmacokinetics of \[14C\]-BIIL 284 BS after administration of a single oral dose of 25 mg \[14C\]-BIIL 284 BS in 6 healthy volunteers. Tolerability was also assessed.
Timeline
- Start
- 1999-10
- Primary completion
- 1999-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AMELUBANT | Small molecule | 25 mg | Oral |
Indications
No indication recorded.